在细胞因子风暴综合征中使用JAK抑制剂
Camille Keenan1, Sabrin Albeituni1, Kim E Nichols1
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Advances in experimental medicine and biology
|August 8, 2024
概括
细胞因子风暴综合征 (CSS) 是一种严重的超炎症状况. 用JAK抑制剂向Janus激酶 (JAKs) 提供了一种有前途的治疗策略,以减少炎症并改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 细胞因子风暴综合征 (CSS) 是一种危及生命的高炎症状况.
- 促炎性细胞因子驱动CSSs,通常通过Janus激酶 (JAK) 和信号转换器和转录激活器 (STAT) 途径发出信号.
- 一些参与CSSs的细胞因子是JAK/STAT通路激活的下游产物.
研究的目的:
- 评估针对 CSS 中 JAK/STAT 信号的治疗潜力.
- 审查JAK抑制剂在临床前和临床环境中的疗效和安全性.
主要方法:
- 用JAK抑制剂治疗的CSSs临床前模型的审查.
- 对CSS患者使用JAK抑制剂的现有临床证据的分析.
主要成果:
- 在临床前的CSS模型中,JAK抑制剂在改善结果方面表现出有效性.
- 临床证据表明,JAK抑制在管理CSS方面是有效的.
- 雅克抑制剂通常耐受良好,但具有风险,特别是与同时存在的末端器官功能障碍.
结论:
- 用JAK抑制剂准JAK/STAT信号是一种可行的CSS治疗方法.
- 需要进行进一步的前性临床试验,以优化JAK抑制剂治疗CSS,包括剂量,时间表和组合策略.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124
Antihypertensive Drugs: Direct Renin Inhibitors
517
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
517
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K


